This study provides important insights into the anticancer potential of MAE, demonstrating its ability to reduce viability, modulate key molecular markers (p53, Ki-67, MMP-9, STAT-3), and affect multiple hallmarks of metastasis in MDA-MB-231 triple-negative breast cancer cells. Here, TP53 is linked to triple-negative breast carcinoma.